Patent approved for CRISPR use in T-cells in Europe – UPI.com
UPI.com |
Patent approved for CRISPR use in T-cells in Europe
UPI.com Dr. André Choulika, chairman and CEO at Cellectis, said his company plans to use the method of using RNA-guided endonucleases like Cas9 or Cpf1 for the genetic engineering of T-cells in research. CRISPR stands for Clustered Regularly Interspaced Short … |
